Latest GENE reports update at 2022-08-30: 2022 ∙ 2021 ∙ 2020

Genetic Technologies Limited GENE

$ 2.32 3.12%

Genetic Technologies Limited Balance Sheet 2011-2024 | GENE

Annual Balance Sheet Genetic Technologies Limited

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-11.1 M	-20.7 M	-13.9 M	-2.13 M	-5.49 M	-11 M	-11.2 M	-18.3 M	-326 K	-1.72 M	-8.88 M	-5.04 M
Long Term Debt	388 K	24.4 K	52.3 K	-	-	-	-	-	2.5 M	-	-	-
Long Term Debt Current	264 K	180 K	241 K	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	559 K	33.3 K	243 K	809	3.39 K	64 K	74.3 K	25.3 K	2.58 M	96.2 K	109 K	82.7 K
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	4.37 M	1.44 M	1.64 M	1.49 M	1.45 M	1.53 M	1.41 M	1.76 M	4.9 M	2.56 M	2.04 M	2.11 M
Deferred Revenue	-	-	-	-	-	-	-	77.3 K	153 K	321 K	267 K	164 K
Retained Earnings	-150 M	-143 M	-136 M	-130 M	-123 M	-118 M	-109 M	-101 M	-92.2 M	-82 M	-72.8 M	-67.5 M
Total Assets	20.8 M	23 M	15.6 M	3.27 M	6.17 M	12.1 M	13.3 M	20.7 M	6.73 M	8.32 M	16.4 M	8.92 M
Cash and Cash Equivalents	11.7 M	20.9 M	14.2 M	2.13 M	5.49 M	11 M	-	18.3 M	-	-	-	-
Book Value	16.4 M	21.5 M	14 M	1.77 M	4.71 M	10.6 M	11.9 M	19 M	1.83 M	5.76 M	14.4 M	6.81 M
Total Shareholders Equity	16.4 M	21.5 M	14 M	1.76 M	4.71 M	10.6 M	11.9 M	-	-	-	-	-

All numbers in AUD currency

Quarterly Balance Sheet Genetic Technologies Limited

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	388 K	-	-	-	24.4 K	-	-	-	189 K	-	137 K	-	251 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	559 K	-	-	-	33.3 K	-	-	-	243 K	-	138 K	-	809	-	-	-	3.39 K	-	-	-	64 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	4.37 M	-	-	-	1.44 M	-	-	-	1.64 M	-	1.48 M	-	1.49 M	-	-	-	1.45 M	-	-	-	1.53 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-150 M	-	-	-	-143 M	-	-	-	-136 M	-	-132 M	-	-130 M	-	-	-	-123 M	-	-	-	-118 M	-	-	-	-109 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	20.8 M	-	-	-	23 M	-	-	-	15.6 M	-	4.34 M	-	3.27 M	-	-	-	6.17 M	-	-	-	12.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	11.7 M	-	-	-	20.9 M	-	-	-	14.2 M	-	3.28 M	-	2.13 M	-	3.23 M	-	5.49 M	-	-	-	11 M	-	-	-	11.2 M	-	-	-	11.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	16.4 M	-	-	-	21.5 M	-	-	-	14 M	-	2.86 M	-	1.77 M	-	-	-	4.71 M	-	-	-	10.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	16.4 M	-	-	-	21.5 M	-	-	-	14 M	-	2.86 M	-	1.77 M	-	3.02 M	-	4.71 M	-	-	-	10.6 M	-	-	-	11.9 M	-	-	-	19 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in AUD currency